AI Image
6 surprising risks of quitting GLP-1 weight-loss drugs, according to experts
Fox News • • health
Key Points:
- Many patients discontinue GLP-1 medications like Ozempic, Wegovy, and Zepbound within a year due to side effects such as nausea and gastrointestinal issues, or a preference to avoid long-term medication.
- Stopping GLP-1 treatments can lead to rebound effects including increased hunger and cravings, rapid weight regain, worsening biomarkers like blood sugar and cholesterol, and loss of cardiovascular protection.
- Weight loss from GLP-1s often includes both fat and muscle mass, raising concerns about body composition and physical function when patients regain weight after stopping the medication.
- Mental health impacts are significant, as patients may feel disheartened and lose confidence after experiencing weight regain and metabolic setbacks post-treatment.
- Maintaining progress after discontinuation requires sustainable lifestyle changes, especially in diet, and close collaboration with healthcare providers to monitor health markers and manage weight and blood sugar levels.
